Share on LinkedInShare on LinkedIn

ARTICLE · 02 AUGUST 2019

CBO Report Shows Senate's Bipartisan Bill On Surprise Billing, Drug Prices, Transparency, And More Would Result In Deficit Decrease

Sheppard
Sheppard
Contributor
Sheppard

Sheppard

Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more...

View firm profile
Explore more from Sheppard

On July 16, 2019, the Congressional Budget Office ("CBO") released a Cost Estimate for Senate Bill S. 1895, the "Lower Health Care Costs Act.

United StatesFood, Drugs, Healthcare, Life Sciences

On July 16, 2019, the Congressional Budget Office ("CBO") released a Cost Estimate for Senate Bill S. 1895, the "Lower Health Care Costs Act." The bipartisan bill, introduced June 19, 2019, intends to end surprise medical bills, reduce the prices of prescription drugs, improve transparency in health care costs, and increase public health awareness and access to health information.

The legislation would implement a number of reforms to the manner in which health care is currently provided. Among the sweeping and far-reaching changes proposed, key provisions include protections for patients from out-of-network expenses for services provided at in-network facilities; prohibitions on drug manufacturers delaying the market entry of generics or biosimilars; a ban on gag clauses on price and product information; a ban on anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care; and funding for a national public awareness

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from